Pulmonary Arterial Hypertension Market Forecast
Market Overview The Pulmonary Arterial Hypertension (PAH) market is positioned for steady and sustained growth over the next decade. Valued at approximately USD 7.7 billion in 2024, the market is projected to reach USD 12.8 billion by 2034, reflecting a compound annual growth rate (CAGR) of around 5.5%. This upward trajectory underscores the growing clinical focus on rare cardiovascular...
0 Commenti 0 condivisioni 94 Views 0 Anteprima
Sponsorizzato